12
Shire ADHD Transitions Challenge Webinar Presentation Date: February 6th, 2013

Shire adhd webinar slides draft 040613

Embed Size (px)

Citation preview

Page 1: Shire adhd webinar slides draft 040613

Shire ADHD Transitions Challenge

Webinar Presentation

Date: February 6th, 2013

Page 2: Shire adhd webinar slides draft 040613

On today’s call:

Tom Curatolo

Senior Director, Commercial Strategy

Shire Pharmaceuticals

JL Neptune

Senior Vice President

Health 2.0

Jenn Stone

Challenge Manager

Health 2.0

Page 3: Shire adhd webinar slides draft 040613

Agenda for Today’s Meeting

  Shire Pharmaceuticals Overview

  ADHD Background

  Challenge Goals   About the Phases

  Evaluation Criteria   Timeline

  Q & A

Page 4: Shire adhd webinar slides draft 040613

Shire Pharmaceuticals

Focused Specialty Pharmaceutical Company   2011 Revenues of $4.3 billion

  ~5,200 employees

Chesterbrook, PA

Specialty Pharmaceuticals

66%

Lexington, MA

Human Genetic Therapies

31%

San Diego, CA

Regenerative Medicine

3%

Page 5: Shire adhd webinar slides draft 040613

Shire Pharmaceuticals

We unleash the potential of people affected by Behavioral Health disorders by creating holistic solutions to help them lead better lives

Priorities:

  Better address unmet patient needs in ADHD

  Diversify beyond Rx Therapy

Vision

Page 6: Shire adhd webinar slides draft 040613

Background

 About Attention-Deficit/Hyperactivity Disorder (ADHD)   In the US, 9.5%* of children and 4.4%† of adults are affected by

ADHD

  Characterized by inattention, hyperactivity and impulsivity

  Symptoms often manifest differently in adulthood (predominately inattention)

  Patients navigate significant transitions during their journey to adulthood:   Relationships, school, work

* Based on a 2007 survey of school-aged children (ages 4-17 years) who were reported by their parents to have ever been diagnosed with ADHD. ���† Based on a survey of US adults ages 18-44 years.

Page 7: Shire adhd webinar slides draft 040613

Challenge Goals

  Areas to address

 Transition from high-school to college

 Transition from college to the workforce

 Daily organizational and life management challenges

 Connection with the healthcare system and encouragement of medication adherence

Page 8: Shire adhd webinar slides draft 040613

The Challenge

  Phase I – Ideation  Submission requirements: concept mock-up and documentation  Awards: Five finalists awarded $5,000 each and continue to

Phase II

  Phase II – Development  Eligibility: Phase I finalist  Submission requirements: demo video, slide deck, and app (if

provisional winner)  Awards: First Place $100,000, Second Place $20,000, Third

Place $5,000

Page 9: Shire adhd webinar slides draft 040613

Evaluation Criteria

  Phase I  Potential impact to improve the quality of life for application

users.  Potential to connect users to health resources

 Design, usability and intuitiveness of application

 Creativity and innovation

 Market potential and opportunity for commercialization

Page 10: Shire adhd webinar slides draft 040613

Evaluation Criteria

  Phase II   Technical Development (i.e. Complexity and functionality of

what was built)   Potential impact to improve the quality of life for application

users.   Potential to connect users to health resources   Design, usability and intuitiveness of application   Creativity and innovation   Market potential and opportunity for commercialization

Page 11: Shire adhd webinar slides draft 040613

Timeline

  Phase I submission phase ends: March 17, 2013

  Phase II start: August 16, 2013

  Phase II end: August 18, 2013

  Winners announced:

Health 2.0 Fall 2013 Conference

September 30 - October 2

Page 12: Shire adhd webinar slides draft 040613

Questions?

www.health2challenge.com

Contact Jenn Stone at:

[email protected]